Ad hoc-Release according § 15 WpHG: Personalia: Change in the Management Board of MEDICLIN Aktiengesellschaft

High investments and a focus on areas with strong growth will secure solid growth of Mediclin in the years to come – integrated medical care is still an importart issue of the company‘s strategy

MediClin AG: Group sales increased to EUR 509.7 mill., preliminary Group operating result amounts to EUR 4.3 mill.

Ad hoc-Release according § 15 WpHG: MediClin AG: Despite increased Group sales the preliminary Group operating result is below expectations

Group sales of the first nine months of FY 2012 increased by 4.4 percent

Group sales of the first half-year of 2012 increased by EUR 11.2 million up to EUR 254.1 million

The Company strategy of MediClin is a model of success

Sales increased by EUR 5.4 million in the first Quarter of 2012

Dr. Ulrich Wandschneider shall become Chairman of the Supervisory Board of MediClin

Business Development of MediClin in FY 2011